#BEGIN_DRUGCARD DB03971

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C37H63NO28

# Chemical_IUPAC_Name:
(2S,3S,4R,5R,6S)-6-({[(2R,3R,4R,5S,6S)-5-{[(2S,3R,4S,5S,6R)-5-{[(1S,4R,5S,6R)-4-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Acarbose Derived Hexasaccharide

# HET_ID:
6SA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C37H63NO28/c1-8-15(19(46)26(53)35(59-8)65-31-12(5-41)62-34(28(55)23(31)50)58-7-14-18(45)20(47)25(52)33(57)60-14)38-10-2-9(3-39)30(22(49)16(10)43)64-37-29(56)24(51)32(13(6-42)63-37)66-36-27(54)21(48)17(44)11(4-40)61-36/h2,8,10-57H,3-7H2,1H3/t8-,10+,11+,12+,13-,14+,15-,16-,17+,18+,19+,20-,21-,22+,23-,24-,25+,26-,27+,28-,29-,30-,31-,32-,33+,34-,35+,36-,37+/m1/s1

# InChI_Key:
InChIKey=MBNITLCAVXHYER-AGOKNQOUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3971

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
969.886

# Molecular_Weight_Mono:
969.353660437

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XD1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.7

# Predicted_LogS:
-0.98

# Predicted_Water_Solubility:
1.01e+02 g/l

# Primary_Accession_No:
DB03971

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936851

# PubChem_Substance_ID:
46506963

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00291

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H]1O[C@@H](O[C@@H]2[C@H](CO)O[C@@H](OC[C@@H]3O[C@H](O)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:48 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
AMY2A

# Phase_1_Metabolizing_Enzyme_1_ID:
4513

# Phase_1_Metabolizing_Enzyme_1_Name:
Pancreatic alpha-amylase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Pancreatic alpha-amylase
MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGL
LDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P04746

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M36539

# Drug_Target_1_GenBank_ID_Protein:
142501

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
amyM

# Drug_Target_1_Gene_Sequence:
>2154 bp
ATGAAAAAGAAAACGCTTTCTTTATTTGTGGGACTGATGCTCCTCATCGGTCTTCTGTTC
AGCGGTTCTCTTCCGTACAATCCAAACGCCGCTGAAGCCAGCAGTTCCGCAAGCGTCAAA
GGGGACGTGATTTACCAGATTATCATTGACCGGTTTTACGATGGGGACACGACGAACAAC
AATCCTGCCAAAAGTTATGGACTTTACGATCCTACCAAATCGAAGTGGAAAATGTATTGG
GGCGGGGATCTGGAGGGGGTTCGTCAAAAACTTCCTTATCTTAAACAGCTGGGCGTAACG
ACAATCTGGTTGTCCCCGGTTTTGAACAATCTGGATACACTGGCGGGCACCGATAACACG
GGCTATCACGGATACTGGACGCGCGATTTTAAACAGATTGAGGAACATTTCGGGAATTGG
ACCACATTTGACACGTTGGTCAATGATGCTCACCAAAACGGAATCAAGGTGATTGTCGAC
TTTGTGCCCAATCATTCGACTCCTTTTAAGGCAAACGATTCCACCTTTGCGGAAGGCGGC
GCCCTCTACAACAATGGAACCTATATGGGCAATTATTTTGATGACGCAACAAAAGGGTAC
TTCCACCATAATGGGGACATCAGCAACTGGGACGACCGGTACGAGGCGCAATGGAAAAAC
TTCACGGATCCAGCCGGTTTCTCGCTTGCCGATTTGTCGCAGGAAAATGGCACGATTGCT
CAATACCTGACCGATGCGGCGGTTCAATTGGTAGCACATGGTTTGCGGATTGATGCGGTG
AAGCATTTTAATTCGGGGTTCTCCAAATCGTTGGCCGATAAACTGTACCAAAAGAAAGAC
ATTTTCCTGGTGGGGGAATGGTACGGAGATGACCCCGGAACAGCCAATCATCTGGAAAAG
GTCCGGTACGCCAACAACAGCGGTGTCAATGTGCTGGATTTTGATCTCAACACGGTGATT
CGAAATGTGTTCGGCACATTTACGCAAACGATGTACGATCTTAACAATATGGTGAACCAA
ACGGGGAACGAGTACAAATACAAAGAAAATCTAATCACATTTATCGATAACCATGATATG
TCAAGATTTCTTTCGGTAAATTCGAAGAACAAGGCGAATTTGCACCAGCGCTTGCTTTCA
TTCTCACTTCGCGGGGTACGCCCTCCCATCTATTATGGAACCGAACAATACATGGCAGGC
GGCAATGACCCGTACAACCGGGGGATGATGCCGGCGTTTGATACGACAACCACCGCCTTT
AAAGAGGTGTCAACTCTGGCGGGGTTGCGCAGGAACAATGCGGCGATCCAGTACGGCACC
ACCACCCAGCGCTGGATCAACAATGATGTTTACATTTATGAACGGAAATTTTTCAACGAT
GTCGTGTTGGTGGCCATCAATCGAAACACGCAATCCTCCTATTCGATTTCCGGTTTGCAG
ACGGCCTTGCCAAATGGCAGCTATGCGGATTATCTGTCAGGGCTGTTGGGGGGGAACGGG
ATTTCCGTTTCCAATGGAAGTGTCGCTTCGTTCACGCTTGCGCCTGGAGCCGTGTCTGTT
TGGCAGTACAGCACATCCGCTTCAGCGCCGCAAATCGGATCGGTTGCTCCAAATATGGGG
ATTCCGGGTAATGTGGTCACGATCGACGGGAAAGGTTTTGGGACGACGCAGGGAACCGTG
ACATTTGGCGGAGTGACAGCGACTGTGAAATCCTGGACATCCAATCGGATTGAAGTGTAC
GTTCCCAACATGGCCGCCGGGCTGACCGATGTGAAAGTCACCGCGGGTGGAGTTTCCAGC
AATCTGTATTCTTACAATATTTTGAGTGGAACGCAGACATCGGTTGTGTTTACTGTGAAA
AGTGCGCCTCCGACCAACCTAGGGGATAAGATTTACCTGACGGGCAACATACCGGAATTG
GGGAATTGGAGCACGGATACGAGCGGAGCCGTTAACAATGCGCAAGGGCCCCTGCTCGCG
CCCAATTATCCGGATTGGTTTTATGTATTCAGCGTTCCAGCAGGAAAGACGATTCAATTC
AAGTTCTTCATCAAGCGTGCGGATGGAACGATTCAATGGGAGAATGGTTCGAACCACGTG
GCCACAACTCCCACGGGTGCAACCGGTAACATTACTGTTACGTGGCAAAACTAG

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
10387084	Dauter Z, Dauter M, Brzozowski AM, Christensen S, Borchert TV, Beier L, Wilson KS, Davies GJ: X-ray structure of Novamyl, the five-domain "maltogenic" alpha-amylase from Bacillus stearothermophilus: maltose and acarbose complexes at 1.7A resolution. Biochemistry. 1999 Jun 29;38(26):8385-92.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2978

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
78676

# Drug_Target_1_Name:
Maltogenic alpha-amylase

# Drug_Target_1_Number_of_Residues:
719

# Drug_Target_1_PDB_ID:
1QHP

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_1_Protein_Sequence:
>Maltogenic alpha-amylase precursor
MKKKTLSLFVGLMLLIGLLFSGSLPYNPNAAEASSSASVKGDVIYQIIIDRFYDGDTTNN
NPAKSYGLYDPTKSKWKMYWGGDLEGVRQKLPYLKQLGVTTIWLSPVLDNLDTLAGTDNT
GYHGYWTRDFKQIEEHFGNWTTFDTLVNDAHQNGIKVIVDFVPNHSTPFKANDSTFAEGG
ALYNNGTYMGNYFDDATKGYFHHNGDISNWDDRYEAQWKNFTDPAGFSLADLSQENGTIA
QYLTDAAVQLVAHGADGLRIDAVKHFNSGFSKSLADKLYQKKDIFLVGEWYGDDPGTANH
LEKVRYANNSGVNVLDFDLNTVIRNVFGTFTQTMYDLNNMVNQTGNEYKYKENLITFIDN
HDMSRFLSVNSNKANLHQALAFILTSRGTPSIYYGTEQYMAGGNDPYNRGMMPAFDTTTT
AFKEVSTLAGLRRNNAAIQYGTTTQRWINNDVYIYERKFFNDVVLVAINRNTQSSYSISG
LQTALPNGSYADYLSGLLGGNGISVSNGSVASFTLAPGAVSVWQYSTSASAPQIGSVAPN
MGIPGNVVTIDGKGFGTTQGTVTFGGVTATVKSWTSNRIEVYVPNMAAGLTDVKVTAGGV
SSNLYSYNILSGTQTSVVFTVKSAPPTNLGDKIYLTGNIPELGNWSTDTSGAVNNAQGPL
LAPNYPDWFYVFSVPAGKTIQFKFFIKRADGTIQWENGSNHVATTPTGATGNITVTWQN

# Drug_Target_1_Reaction:
hydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides so as to remove successive alpha-maltose residues from the non-reducing ends of the chains

# Drug_Target_1_Signals:
1-33

# Drug_Target_1_Specific_Function:
Converts starch into maltose

# Drug_Target_1_SwissProt_ID:
P19531

# Drug_Target_1_SwissProt_Name:
AMYM_GEOSE

# Drug_Target_1_Synonyms:
EC 3.2.1.133
Glucan 1,4-alpha- maltohydrolase
Maltogenic alpha-amylase precursor

# Drug_Target_1_Theoretical_pI:
5.95

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Secreted protein

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
AMY2A

# Drug_Target_2_GenBank_ID_Gene:
M18785

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
AMY2A

# Drug_Target_2_Gene_Sequence:
>1536 bp
ATGAAGTTCTTTCTGTTGCTTTTCACCATTGGGTTCTGCTGGGCTCAGTATTCCCCAAAT
ACACAACAAGGACGGACATCTATTGTTCATCTGTTTGAATGGCGATGGGTTGATATTGCT
CTTGAATGTGAGCGATATTTAGCTCCGAAGGGATTTGGAGGGGTTCAGGTCTCTCCACCA
AATGAAAATGTTGCAATTTACAACCCTTTCAGACCTTGGTGGGAAAGATACCAACCAGTT
AGCTATAAATTATGCACAAGATCTGGAAATGAAGATGAATTTAGAAACATGGTGACTAGA
TGTAACAATGTTGGGGTTCGTATTTATGTGGATGCTGTAATTAATCATATGTGTGGTAAC
GCTGTGAGTGCAGGAACAAGCAGTACCTGTGGAAGTTACTTCAACCCTGGAAGTAGGGAC
TTTCCAGCAGTCCCATATTCTGGATGGGATTTCAATGATGGTAAATGTAAAACTGGAAGT
GGAGATATCGAGAACTACAATGATGCTACTCAGGTCAGAGATTGTCGTCTGACTGGTCTT
CTTGATCTTGCACTGGAGAAGGATTACGTGCGTTCTAAGATTGCCGAATATATGAACCAT
CTCATTGACATTGGTGTTGCAGGGTTCAGACTTGATGCTTCCAAGCACATGTGGCCTGGA
GACATAAAGGCAATTTTGGACAAACTGCATAATCTAAACAGTAACTGGTTCCCTGCAGGA
AGTAAACCTTTCATTTACCAGGAGGTAATTGATCTGGGTGGTGAGCCAATTAAAAGCAGT
GACTACTTTGGTAATGGCCGGGTGACAGAATTCAAGTATGGTGCAAAACTCGGCACAGTT
ATTCGCAAGTGGAATGGAGAGAAGATGTCTTACTTAAAGAACTGGGGAGAAGGTTGGGGT
TTCGTACCTTCTGACAGAGCGCTTGTCTTTGTGGATAACCATGACAATCAACGAGGACAT
GGGGCTGGAGGAGCCTCTATTCTTACCTTCTGGGATGCTAGGCTGTACAAAATGGCAGTT
GGATTTATGCTTGCTCATCCTTACGGATTTACACGAGTAATGTCAAGCTACCGTTGGCCA
AGACAGTTTCAAAATGGAAACGATGTTAATGATTGGGTTGGGCCACCAAATAATAATGGA
GTAATTAAAGAAGTTACTATTAATCCAGACACTACTTGTGGCAATGACTGGGTCTGTGAA
CATCGATGGCGCCAAATAAGGAACATGGTTATTTTCCGCAATGTAGTGGATGGCCAGCCT
TTTACAAATTGGTATGATAATGGGAGCAACCAAGTGGCTTTTGGGAGAGGAAACAGAGGA
TTCATTGTTTTCAACAATGATGACTGGTCATTTTCTTTAACTTTGCAAACTGGTCTTCCT
GCTGGCACATACTGTGATGTCATTTCTGGAGATAAAATTAATGGCAATTGCACAGGCATT
AAAATTTACGTTTCTGATGATGGCAAAGCTCATTTTTCTATTAGTAACTCTGCTGAAGAT
CCATTTATTGCAATTCATGCTGAATCTAAATTGTAA

# Drug_Target_2_General_Function:
Involved in alpha-amylase activity

# Drug_Target_2_General_References:
10091666	Rydberg EH, Sidhu G, Vo HC, Hewitt J, Cote HC, Wang Y, Numao S, MacGillivray RT, Overall CM, Brayer GD, Withers SG: Cloning, mutagenesis, and structural analysis of human pancreatic alpha-amylase expressed in Pichia pastoris. Protein Sci. 1999 Mar;8(3):635-43.
2450054	Horii A, Emi M, Tomita N, Nishide T, Ogawa M, Mori T, Matsubara K: Primary structure of human pancreatic alpha-amylase gene: its comparison with human salivary alpha-amylase gene. Gene. 1987;60(1):57-64.
2452973	Gumucio DL, Wiebauer K, Caldwell RM, Samuelson LC, Meisler MH: Concerted evolution of human amylase genes. Mol Cell Biol. 1988 Mar;8(3):1197-205.
3260028	Groot PC, Bleeker MJ, Pronk JC, Arwert F, Mager WH, Planta RJ, Eriksson AW, Frants RR: Human pancreatic amylase is encoded by two different genes. Nucleic Acids Res. 1988 May 25;16(10):4724.
6336237	Wise RJ, Karn RC, Larsen SH, Hodes ME, Gardell SJ, Rutter WJ: A complementary DNA sequence that predicts a human pancreatic amylase primary structure consistent with the electrophoretic mobility of the common isozyme, Amy2 A. Mol Biol Med. 1984 Oct;2(5):307-22.
6610603	Nishide T, Emi M, Nakamura Y, Matsubara K: Corrected sequences of cDNAs for human salivary and pancreatic alpha-amylases [corrected] Gene. 1984 May;28(2):263-70.
8193143	Qian M, Haser R, Buisson G, Duee E, Payan F: The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution. Biochemistry. 1994 May 24;33(20):6284-94.
8528071	Brayer GD, Luo Y, Withers SG: The structure of human pancreatic alpha-amylase at 1.8 A resolution and comparisons with related enzymes. Protein Sci. 1995 Sep;4(9):1730-42.

# Drug_Target_2_HGNC_ID:
HGNC:477

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4513

# Drug_Target_2_Locus:
1p21

# Drug_Target_2_Molecular_Weight:
57707

# Drug_Target_2_Name:
Pancreatic alpha-amylase

# Drug_Target_2_Number_of_Residues:
511

# Drug_Target_2_PDB_ID:
1B2Y

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_2_Protein_Sequence:
>Pancreatic alpha-amylase
MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGL
LDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-15

# Drug_Target_2_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_2_SwissProt_ID:
P04746

# Drug_Target_2_SwissProt_Name:
AMYP_HUMAN

# Drug_Target_2_Synonyms:
1,4-alpha-D- glucan glucanohydrolase
EC 3.2.1.1
PA
Pancreatic alpha-amylase precursor

# Drug_Target_2_Theoretical_pI:
7.05

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03971
